Clinical Research Forum named the BIOS CTCC study Early Outpatient COVID-19 Plasma Treatment Research Study (CSSC-004) one of the Top 10 2023 Clinical Research Achievement…
The Early Outpatient COVID-19 Plasma Treatment Research Study (CSSC-004) has been named a finalist for the 2023 Clinical Research Achievement Awards. The Clinical Research Achievement…
The Early Outpatient COVID-19 Plasma Treatment Research Study (CSSC-004) had its final results published in The New England Journal of Medicine on March 30th, 2022.…